SVRA CIK: 1160308

Savara Inc

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
165
FY22:
129
FY23:
166
FY24:
202
FY25:
242
(positive)
Change from FY21 to FY25
millions USD
FY21:
11.6
FY22:
10.8
FY23:
11.6
FY24:
10.7
FY25:
11.8
Total assets
Change from FY21 to FY25
millions USD
FY21:
177
FY22:
140
FY23:
178
FY24:
213
FY25:
253

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
14.7
FY22:
5.87
FY23:
10.6
FY24:
14.7
FY25:
20.4
(negative)
Change from FY21 to FY25
millions USD
FY21:
17.4
FY22:
26.1
FY23:
26.6
FY24:
26.7
FY25:
29.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
144
FY22:
108
FY23:
140
FY24:
171
FY25:
203
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
177
FY22:
140
FY23:
178
FY24:
213
FY25:
253

All amounts in millions USD Data source:SEC EDGAR